The Complete Guide to Third Party Pharma Manufacturing in India
India has firmly established itself as the global hub for pharmaceutical production. As healthcare demands rise globally, many companies are turning to third party pharma manufacturing in India to meet their supply requirements without the heavy overhead of building their own facilities. This model allows businesses to focus on marketing, sales, and distribution while relying on specialized partners to handle the complex and highly regulated production process.
If you are a pharmaceutical company, a startup entering the healthcare space, or an international buyer looking to source high-quality medicines, understanding how contract manufacturing works is crucial. This guide covers the benefits, process, and key factors to consider when selecting a partner for pharmaceutical production in India.
What is Third Party Pharma Manufacturing?
Third party manufacturing, also known as contract manufacturing, is a business model where a pharmaceutical company outsources the production of its products to a specialized manufacturer. The hiring company provides the product specifications, brand name, and packaging design, while the third party handles the actual formulation, manufacturing, quality testing, and packaging.
This arrangement is highly popular in India due to the country's vast network of advanced manufacturing units, skilled workforce, and cost-effective production capabilities. Contract Development and Manufacturing Organizations (CDMO) take this a step further by offering research, development, and scaling services alongside standard manufacturing.
By leveraging third party pharma manufacturing in India, companies can rapidly scale their product portfolios without investing millions in physical infrastructure, machinery, and regulatory compliance teams.
Why Choose India for Pharma Contract Manufacturing?
India is often referred to as the pharmacy of the world. The country supplies a significant portion of global generic drugs and vaccines. Several factors make India the preferred destination for pharmaceutical outsourcing.
Cost-Effective Production
One of the primary drivers for choosing Indian manufacturers is the significant cost advantage. Setting up a pharmaceutical manufacturing plant requires massive capital investment in specialized machinery, cleanrooms, and ongoing maintenance. By partnering with a third party, companies convert fixed capital costs into variable operational costs. Furthermore, the cost of skilled labor, raw materials, and operations in India is considerably lower than in Western countries, allowing for highly competitive pricing.
Uncompromised Quality and Certifications
Quality is non-negotiable in healthcare. Top manufacturers in India operate facilities that adhere to stringent global standards. A reliable partner will be a WHO-GMP certified manufacturer. WHO-GMP (World Health Organization Good Manufacturing Practices) certification ensures that products are consistently produced and controlled according to quality standards. Additionally, many facilities hold ISO certifications and comply with the guidelines set by major international regulatory bodies, including the US FDA, UK MHRA, and European EMA.
Scalability and High Production Capacity
Indian pharmaceutical facilities are built for scale. Whether a company needs a small batch for a niche market or large-scale production for a mass-market generic drug, third party manufacturers can adapt to changing volume requirements. This flexibility allows businesses to respond quickly to market demands, seasonal fluctuations in drug requirements, and sudden supply chain disruptions.
Focus on Core Competencies
By outsourcing the heavy lifting of production, pharmaceutical marketing companies and brand owners can redirect their resources, time, and focus toward their core competencies. This includes research, branding, marketing, sales, and expanding their distribution networks. The CDMO handles the complexities of raw material procurement, formulation, quality control, and regulatory paperwork.
The Process of Third Party Pharma Manufacturing in India
Engaging a contract manufacturer involves a systematic process to ensure quality, legal compliance, and timely delivery. Here is a step-by-step breakdown of how the process generally works.
1. Finalizing the Product List and Formulations
The first step is to clearly define what needs to be manufactured. The hiring company selects the products, dosages (such as tablets, capsules, syrups, or injectables), and specific formulations. If the product is a standard generic, the manufacturer may already have an approved formula. For novel products, the CDMO might assist in the development and stability testing phases.
2. Checking Regulatory Approvals and Licenses
Before production can begin, the manufacturer must have the legal right to produce the specific formulation. If the third party does not already possess the manufacturing license for the requested product from the State Drug Control Department, they must apply for it. The hiring company must also provide their marketing licenses, trademark registration for brand names, and GST registration details.
3. Finalizing Pricing, Terms, and Agreements
Once the product list is finalized, both parties negotiate the pricing. This includes the cost of raw materials, packaging, manufacturing charges, quality testing fees, and taxation. After agreeing on the commercial terms, a formal manufacturing agreement is signed. This contract outlines quality standards, delivery timelines, payment terms, and intellectual property protection.
4. Designing the Packaging
Packaging plays a critical role in pharmaceutical marketing and product stability. The hiring company provides the brand names, logos, and color schemes. The manufacturer's design team or an external agency creates the packaging layouts (cartons, foils, labels) ensuring they comply with all statutory labeling requirements mandated by the drug regulatory authorities.
5. Production and Quality Control
Once the packaging material is printed and raw materials are procured, the actual production begins. The manufacturing process happens under strict WHO-GMP guidelines. Throughout production, quality control (QC) teams monitor the process. After the batch is completed, it undergoes rigorous laboratory testing to ensure it meets all safety, efficacy, and stability parameters before it is released for dispatch.
6. Dispatch and Delivery
After clearing quality assurance, the finished goods are dispatched to the hiring company's warehouse or designated distribution centers, accompanied by all necessary testing reports and invoices.
Key Factors to Consider When Selecting a CDMO in India
Choosing the right partner for third party pharma manufacturing in India is a critical business decision. A poor choice can lead to supply delays, quality issues, and reputational damage. Here are the most important criteria to evaluate.
Certifications and Compliance
The foundational requirement is regulatory compliance. Ensure the facility is at least a WHO-GMP certified manufacturer. If you plan to export to specific regions, verify that the facility holds the necessary approvals for those markets (e.g., EU-GMP, US FDA). ISO certifications also indicate a strong commitment to quality management systems.
Production Capabilities and Infrastructure
Evaluate the manufacturer's infrastructure. Do they have dedicated blocks for specific product categories like beta-lactams, cephalosporins, or hormones? Cross-contamination is a serious risk in pharmaceutical manufacturing, so modern facilities with advanced HVAC systems and strict segregation are essential. Additionally, verify their production capacity to ensure they can meet your volume requirements without delays.
Quality Assurance and Laboratory Facilities
A reliable CDMO must have a robust in-house quality control laboratory equipped with modern analytical instruments like HPLC and GC machines. They should be transparent about their testing protocols for raw materials, in-process samples, and finished products. Ask for past audit reports and their Standard Operating Procedures (SOPs) for handling deviations.
Market Reputation and Client Portfolio
Research the manufacturer's track record. A company with years of experience and a portfolio of reputable clients is generally a safer bet. Look for reviews, ask for references, and assess their financial stability. A financially stable partner is less likely to cut corners on quality or face sudden operational shutdowns.
Supply Chain and Delivery Timelines
Timely delivery is crucial in the pharmaceutical supply chain. Delays can lead to stock-outs and lost sales. Discuss lead times clearly before signing the contract. An experienced manufacturer will have strong relationships with raw material suppliers, reducing the risk of production delays due to material shortages.
The Future of Pharma Outsourcing
The landscape of pharmaceutical outsourcing is evolving. As the industry faces increasing pressure to reduce costs and accelerate time-to-market, the reliance on contract manufacturing is expected to grow. India will continue to play a dominant role, moving beyond simple generic manufacturing into more complex areas such as biosimilars, high-potency active pharmaceutical ingredients (HPAPIs), and specialized delivery systems.
Companies that build strong, long-term relationships with capable CDMOs in India will be well-positioned to navigate the complexities of the global pharmaceutical market, ensuring a steady supply of high-quality medicines for their patients.
Frequently Asked Questions
What is the minimum batch size for contract manufacturing?
Minimum batch sizes vary significantly depending on the manufacturer and the type of product. For tablets and capsules, it can range from 50,000 to 100,000 units. For specialized items like injectables, the minimum requirement might be lower. It is best to negotiate this directly with the manufacturer based on your market needs.
How long does the third party manufacturing process take?
For a new product where packaging needs to be designed and drug licenses need to be acquired, the initial process can take 45 to 60 days. Once the setup is complete, subsequent repeat orders usually take 30 to 45 days, depending on raw material availability and production schedules.
Can a company without a drug license get medicines manufactured?
No. To market pharmaceutical products in India, the marketing company must possess a valid wholesale drug license. The manufacturing license is held by the third-party manufacturer, but the entity selling the products must be legally authorized to trade in pharmaceuticals.
Does the manufacturer help with product formulation?
Yes, most established contract manufacturers and CDMOs have in-house research and development teams that can assist with formulation development, stability studies, and process validation for new or modified products.
This article is published by Celesta Healthcare, a WHO-GMP certified pharmaceutical manufacturer in Pune, India.